Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial — A. Pieter Kappetein (2011) | RDL Network
Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial
European Heart Journal 32(17): 2125-2134
Article 2011 English
Authors
AK
A. Pieter Kappetein
TF
Ted Feldman
MM
Michael J. Mack
Abstract
1 min read
AimsLong-term randomized comparisons of percutaneous coronary intervention (PCI) to coronary artery bypass grafting (CABG) in left main coronary (LM) disease and/or three-vessel disease (3VD) patients have been limited. This analysis compares 3-year outcomes in LM and/or 3VD patients treated with CABG or PCI with TAXUS Express stents.
David J. Cohen, Ruben L.J. Osnabrugge, Elizabeth A. Magnuson, Kaijun Wang, Haiyan Li, Khaja Chinnakondepalli, Duane S. Pinto, Mouin Abdallah, Katherine A. Vilain, Marie‐Claude Morice, Keith D. Dawkins, A. Pieter Kappetein, Friedrich W. Mohr, Patrick W. Serruys
Cheol Whan Lee, Jung‐Min Ahn, Rafael Cavalcante, Yohei Sotomi, Yoshinobu Onuma, Pannipa Suwannasom, Erhan Tenekecioğlu, Sung‐Cheol Yun, Duk‐Woo Park, Soo‐Jin Kang, Seung‐Whan Lee, Young‐Hak Kim, Seong‐Wook Park, Patrick W. Serruys, Seung‐Jung Park
Stuart J. Head, Piroze Davierwala, Patrick W. Serruys, Simon Redwood, Antonio Colombo, Michael J. Mack, Marie‐Claude Morice, David R. Holmes, Ted Feldman, Elisabeth Ståhle, Paul Underwood, Keith D. Dawkins, A. Pieter Kappetein, Friedrich W. Mohr
Discussion(0)
No comments yet. Be the first to comment.